Cited by 830Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.

Insulin and neurodegenerative disease: shared and specific mechanisms

Craft, Suzanne, Stennis Watson, G·2004·The Lancet Neurology

DOI 10.1016/s1474-4422(04)00681-7

Open this paper in CoChat — free account

Abstract

Insulin has functions in the brain and dysregulation of these functions may contribute to the expression of late-life neurodegenerative disease. We provide a brief summary of research on the influence of insulin on normal brain function. We then review evidence that perturbation of this role may contribute to the symptoms and pathogenesis of various neurodegenerative disorders, such as Alzheimer's disease, vascular dementia, Parkinson's disease, and Huntington's disease. We conclude by considering whether insulin dysregulation contributes to neurodegenerative disorders through disease-specific or general mechanisms.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(04)00681-7

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Parkinson's Disease
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,526
The Endocrine Regulation of Aging by Insulin-like Signals
Tatar, M., Bartke, A., & Antebi, A. (2003) · Science · doi:10.1126/science.1081447 · Cited by 1,327
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Insulin receptors are widely distributed in the central nervous system of the rat
Havránková, J., Roth, J., & Brownstein, M. (1978) · Nature · doi:10.1038/272827a0 · Cited by 1,116
Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes
Rulifson, E. J., Kim, S. K., & Nusse, R. (2002) · Science · doi:10.1126/science.1070058 · Cited by 1,064

Show all 145 references

Research works printed but not linked: 1

Schobotz, 1976, Fatty acid patterns and glucose tolerance in Huntington's chorea, Res Exp Med (Berl), 167, 203

Sorted by citations

Items 101–200 of 828

Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review
Mittal, K., & Katare, D. P. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.01.021 · Cited by 161
Increased risk of Parkinson disease with diabetes mellitus in a population-based study
Yang, Y.-W., Hsieh, T.-F., Li, C.-I., Liu, C.-S., Lin, W., Chiang, J., Li, T., & Lin, C. (2017) · Medicine · doi:10.1097/md.0000000000005921 · Cited by 152
Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease
Rad, S. K., Arya, A., Karimian, H., Madhavan, P., Rizwan, F., Koshy, S., & Prabhu, G. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s173970 · Cited by 167
GluT4: A central player in hippocampal memory and brain insulin resistance
McNay, E. C., & Pearson-Leary, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113076 · Cited by 159
A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
Tabrez, S. S. M., Jabir, N. R., Shakil, S., Greig, N. H., Alam, Q., Abuzenadah, A. M., Damanhouri, G., & Kamal, M. A. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800792785 · Cited by 153
Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin
Srodulski, S. J., Sharma, S., Bachstetter, A. D., Brelsfoard, J., Pascual, C., Xie, X., Saatman, K. E., Eldik, L. J. V., & Despa, F. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-30 · Cited by 159
Metformin treatment in late middle age improves cognitive function with alleviation of microglial activation and enhancement of autophagy in the hippocampus
Kodali, M., Attaluri, S., Madhu, L. N., Shuai, B., Upadhya, R., Gonzalez, J. J., Rao, X., & Shetty, A. K. (2021) · Aging Cell · doi:10.1111/acel.13277 · Cited by 151
Neuroprotective properties of GLP-1: theoretical and practical applications
Holst, J. J., Burcelin, R., & Nathanson, E. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.549466 · Cited by 154
Aging, lifestyle and dementia
Wahl, D., Solon‐Biet, S. M., Cogger, V. C., Fontana, L., Simpson, S. J., Couteur, D. G. L., & Ribeiro, R. V. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104481 · Cited by 155
Drug development for Alzheimer's disease: where are we now and where are we headed?
Sabbagh, M. N. (2009) · The American journal of geriatric pharmacotherapy · doi:10.1016/j.amjopharm.2009.06.003 · Cited by 147
miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling
Kim, W., Lee, Y., McKenna, N. D., Yi, M., Šimunović, F., Wang, Y., Kong, B., Rooney, R. J., Seo, H., Stephens, R. M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.021 · Cited by 151
Dairy constituents and neurocognitive health in ageing
Camfield, D., Owen, L., Scholey, A. B., Pipingas, A., & Stough, C. K. K. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511000158 · Cited by 151
Insulin resistance and cognitive dysfunction
Ma, L., Wang, J., & Li, Y. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.027 · Cited by 150
EGCG ameliorates high‐fat– and high‐fructose‐induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS
Mi, Y., Qi, G., Fan, R., Qiao, Q., Sun, Y., Gao, Y.-Q., & Liu, X. (2017) · The FASEB Journal · doi:10.1096/fj.201700400rr · Cited by 145
Cognitive Impairment: An Increasingly Important Complication of Type 2 Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik Study
Saczynski, J. S., Jonsdottir, M. K., Garcia, M. E., Jonsson, P. V., Peila, R., Eiriksdottir, G., Olafsdottir, E., Harris, T. B., Gudnason, V., & Launer, L. J. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn228 · Cited by 142
Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration
Duarte, A. I., Candeias, E., Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Plácido, A. I., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.008 · Cited by 149
Adiponectin is Protective against Oxidative Stress Induced Cytotoxicity in Amyloid-Beta Neurotoxicity
Chan, K., Lam, K. S. L., Cheng, O.-Y., Kwan, J., Ho, P. W., Cheng, K. K. Y., Chung, S. K., Ho, J. W.-M., Guo, V. Y., & Xu, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052354 · Cited by 143
Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3β signaling pathways and changes in protein expression
Duarte, A. I., Rodrigues‐Santos, P., Oliveira, C. R., Santos, M. S., & Rego, A. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.02.016 · Cited by 148
Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.03.002 · Cited by 145
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient β-cell mass and exocytosis
Björkqvist, M., Fex, M., Renström, E., Wierup, N., Petersén, Å., Gil‐Mohapel, J., Bacos, K., Popović, N., Li, J., Sundler, F., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi053 · Cited by 143
Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism
Ott, V., Benedict, C., Schultes, B., Born, J., & Hallschmid, M. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01490.x · Cited by 139
Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain
Abolhassani, N., Leon, J., Sheng, Z., Oka, S., Hamasaki, H., Iwaki, T., & Nakabeppu, Y. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.05.005 · Cited by 140
Cerebrovascular Reactivity to Carbon Dioxide in Alzheimer's Disease
Glodzik, L., Randall, C., Rusinek, H., & de Leon, M. J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122011 · Cited by 141
The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function
Schéele, C., Petrovič, N., Faghihi, M. A., Lassmann, T., Fredriksson, K., Rooyackers, O., Wahlestedt, C., Good, L., & Timmons, J. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-74 · Cited by 138
Systemic Hypotheses for Generalized Cognitive Deficits in Schizophrenia: A New Take on An Old Problem
Dickinson, D., & Harvey, P. D. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn097 · Cited by 138
Diabetes, markers of brain pathology and cognitive function
Qiu, C., Sigurdsson, S. O., Zhang, Q., Jónsdóttir, M. K., Kjartansson, Ó., Eiríksdóttir, G., Garcia, M. E., Harris, T. B., van Buchem, M. A., Gudnason, V. G., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24063 · Cited by 143
Biological and neurological activities of astaxanthin (Review)
Si, P., & Zhu, C. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12816 · Cited by 145
Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons
Huang, T.-J., Verkhratsky, A., & Fernyhough, P. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.08.009 · Cited by 139
Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis
Li, Y., Chigurupati, S., Holloway, H. W., Mughal, M. R., Tweedie, D., Bruestle, D. A., Mattson, M. P., Wang, Y., Harvey, B. K., Ray, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032008 · Cited by 131
Insulin dysfunction and Tau pathology
Khoury, N. B. E., Gratuze, M., Papon, M.-A., Bretteville, A., & Planel, E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00022 · Cited by 133
Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-γ systems
Gold, P. W., Licinio, J., & Pavlatou, M. G. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.167 · Cited by 132
Neuronal network disintegration: common pathways linking neurodegenerative diseases
Ahmed, R. M., Devenney, E. M., Irish, M., Ittner, A., Naismith, S., Ittner, L. M., Rohrer, J. D., Halliday, G. M., Eisen, A., Hodges, J. R., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308350 · Cited by 128
Proteolytic mechanisms in amyloid-β metabolism: therapeutic implications for Alzheimer's disease
Vardy, E. R. L. C., Catto, A. J., & Hooper, N. M. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.08.004 · Cited by 135
Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism
Ahmed, R. M., Irish, M., Piguet, O., Halliday, G. M., Ittner, L. M., Farooqi, I. S., Hodges, J. R., & Kiernan, M. C. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00380-4 · Cited by 137
Obesity and insulin resistance are associated with reduced activity in core memory regions of the brain
Cheke, L. G., Bonnici, H. M., Clayton, N. S., & Simons, J. S. (2017) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.01.013 · Cited by 133
Diabetes is associated with postural instability and gait difficulty in Parkinson disease
Kotagal, V., Albin, R. L., Müller, M. L. T. M., Koeppe, R. A., Frey, K. A., & Bohnen, N. I. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.01.016 · Cited by 128
Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort
Valcour, V., Shikuma, C. M., Shiramizu, B. T., Watters, M. R., Poff, P., Selnes, O. A., Grove, J., Liu, Y., Abdul-Majid, K.-B., Gartner, S., et al. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.08.029 · Cited by 127
Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer’s disease
Rahman, S. O., Panda, B. P., Parvez, S., Kaundal, M., Hussain, S., Akhtar, M., & Najmi, A. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.043 · Cited by 131
Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap
McIntyre, R. S., Rasgon, N. L., Kemp, D. E., Nguyen, H. T., Law, C. W. Y., Taylor, V. H., Woldeyohannes, H. O., Alsuwaidan, M. T., Soczynska, J. K., Kim, B., et al. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0010-0 · Cited by 127
Vascular Risk Factors: Imaging and Neuropathologic Correlates
Knopman, D. S., & Roberts, R. O. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091555 · Cited by 123
Weight loss in neurodegenerative disorders
Aziz, N. A., van der Marck, M. A., Pijl, H., Rikkert, M. G. M. O., Bloem, B. R., & Roos, R. A. C. (2008) · Journal of Neurology · doi:10.1007/s00415-009-0062-8 · Cited by 138
Insulin resistance in Alzheimer's disease
Dineley, K. T., Jahrling, J. B., & Denner, L. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.001 · Cited by 125
Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies
Lü, L., Fu, D.-L., Li, H., Liu, A., Li, J.-H., & Zheng, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085781 · Cited by 122
Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?
Vieira, M. N. N., Silva, N. M. L. E., Ferreira, S. T., & Felice, F. G. D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00007 · Cited by 123
White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging
Alfaro, F. J., Gavrieli, A., Saade-Lemus, P., Lioutas, V., Upadhyay, J., & Novak, V. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.009 · Cited by 125
Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease
Zhao, Z., Xiang, Z., Haroutunian, V. H., Buxbaum, J. D., Stetka, B., & Pasinetti, G. M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.001 · Cited by 131
Insulin Sensitivity as a Mediator of the Relationship Between BMI and Working Memory‐Related Brain Activation
Gonzales, M. M., Tarumi, T., Miles, S. C., Tanaka, H., Shah, F., & Haley, A. P. (2010) · Obesity · doi:10.1038/oby.2010.183 · Cited by 129
Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases
Ray, M., Ruan, J., & Zhang, W. (2008) · Genome Biology · doi:10.1186/gb-2008-9-10-r148 · Cited by 119
Insulin Resistance Predicts Medial Temporal Hypermetabolism in Mild Cognitive Impairment Conversion to Alzheimer Disease
Willette, A. A., Modanlo, N., Kapogiannis, D., & Initiative, A. D. N. (2015) · Diabetes · doi:10.2337/db14-1507 · Cited by 118
Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors
Musicco, M., Palmer, K., Salamone, G., Lupo, F., Perri, R., Mosti, S., Spalletta, G., Iulio, F. D., Pettenati, C., Cravello, L., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5116-4 · Cited by 118
Effects of dietary restriction on neuroinflammation in neurodegenerative diseases
Fontana, L., Ghezzi, L., Cross, A. H., & Piccio, L. M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190086 · Cited by 119
Association Between Glycemic Status and the Risk of Parkinson Disease: A Nationwide Population-Based Study
Rhee, S. Y., Han, K.-D., Kwon, H., Park, S.-E., Park, Y.-G., Kim, Y.-H., Yoo, S.-J., Rhee, E.-J., & Lee, W.-Y. (2020) · Diabetes Care · doi:10.2337/dc19-0760 · Cited by 109
Socioeconomic status, BMI, and brain development in children
Dennis, E., Manza, P., & Volkow, N. D. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01779-3 · Cited by 128
Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort
Knopman, D. S., Mosley, T. H., Catellier, D., & Sharrett, A. R. (2005) · Neurology · doi:10.1212/01.wnl.0000176074.09733.a8 · Cited by 115
Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)
Roses, A. D., Saunders, A. M., Huang, Y., Strum, J. C., Weisgraber, K. H., & Mahley, R. W. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500397 · Cited by 109
Hippocampal volume and cognitive performance in long‐standing Type 1 diabetic patients without macrovascular complications
Lobnig, B. M., Krömeke, O., Optenhostert‐Porst, C., & Wolf, O. T. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01716.x · Cited by 112
Type 2 diabetes mellitus, dyslipidemia, and Alzheimer’s disease
Carlsson, C. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100012 · Cited by 109
Insulin resistance, inflammation, and cognition in Alzheimer's Disease: Lessons for multiple sclerosis
Watson, G. S., & Craft, S. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.017 · Cited by 111
Self-citation
Serum high sensitivity C-reactive protein and cognitive function in elderly women
Komulainen, P., Lakka, T. A., Kivipelto, M., Hassinen, M., Penttila, I. M., Helkala, E.-L., Gylling, H. K., Nissinen, A. M., & Rauramaa, R. (2007) · Age and Ageing · doi:10.1093/ageing/afm051 · Cited by 115
The Common Insecticides Cyfluthrin and Chlorpyrifos Alter the Expression of a Subset of Genes with Diverse Functions in Primary Human Astrocytes
Mense, S. M., Sengupta, A., Lan, C., Zhou, M., Bentsman, G., Volsky, D. J., Whyatt, R. M., Perera, F. P., & Li, Z. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl046 · Cited by 109
Effects of adiposity and metabolic dysfunction on cognition: A review
Farruggia, M. C., & Small, D. M. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112578 · Cited by 112
Cognition, Brain Structure, and Brain Function in Individuals with Obesity and Related Disorders
Tanaka, H., Gourley, D., Dekhtyar, M., & Haley, A. P. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00412-y · Cited by 106
A randomized, double‐blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder
McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Miranda, A., Vaccarino, A., MacQueen, G., Lewis, G. F., & Kennedy, S. H. (2012) · Bipolar Disorders · doi:10.1111/bdi.12006 · Cited by 104
Spatial memory impairments in a prediabetic rat model
Soares, E. F. P., Prediger, R. D., Nunes, S., de Castro, A. A., Viana, S., Lemos, C., Souza, C. M. D. A., Agostinho, P. M., Cunha, R. A., Carvalho, E., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.055 · Cited by 110
Body Mass Index, Diabetes, and the Risk of Parkinson's Disease
Jeong, S., Han, K., Kim, D., Rhee, S. Y., Jang, W., & Shin, D. W. (2019) · Movement Disorders · doi:10.1002/mds.27922 · Cited by 104
Vascular and metabolic dysfunction in Alzheimer’s disease: a review
Murray, I. V. J., Proza, J. F., Sohrabji, F., & Lawler, J. M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010355 · Cited by 104
Converging miRNA functions in diverse brain disorders: A case for miR-124 and miR-126
Sonntag, K., Woo, T.-U. W., & Krichevsky, A. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.035 · Cited by 107
Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors
Denley, A., Carroll, J. M., Brierley, G. V., Cosgrove, L., Wallace, J., Forbes, B., & Roberts, C. T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01447-06 · Cited by 103
Extended tracts of homozygosity identify novel candidate genes associated with late-onset Alzheimer’s disease
Nalls, M. A., Guerreiro, R. J., Simón‐Sánchez, J., Brás, J., Traynor, B. J., Gibbs, J. R., Launer, L. J., Hardy, J., & Singleton, A. (2009) · Neurogenetics · doi:10.1007/s10048-009-0182-4 · Cited by 103
The effects of cardiovascular risk factors on cognitive compromise
Beeri, M. S., Ravona‐Springer, R., Silverman, J. M., & Haroutunian, V. H. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/msbeeri · Cited by 101
Insulin Resistance, Type 2 Diabetes Mellitus, and Cardiovascular Disease: The End of the Beginning
Reaven, G. (2005) · Circulation · doi:10.1161/circulationaha.105.504670 · Cited by 98
Detrimental effects of a high fat/high cholesterol diet on memory and hippocampal markers in aged rats
Ledreux, A., Wang, X., Schultzberg, M., Granholm, A., & Freeman, L. R. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.012 · Cited by 99
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
Nasiri, E., Sankowski, R., Dietrich, H., Oikonomidi, A., Huerta, P. T., Popp, J., Al-Abed, Y., & Bacher, M. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00163-5 · Cited by 91
The diabetic brain and cognition
Riederer, P., Korczyn, A. D., Ali, S. S., Bajenaru, O. A., Choi, M. S., Chopp, M., Dobrota, V. Đ., Grünblatt, E., Jellinger, K. A., Kamal, M. A., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1763-2 · Cited by 98
Diabetes, Insulin Resistance, and Dementia Among HIV-1-Infected Patients
Valcour, V., Shikuma, C. M., Shiramizu, B. T., Williams, A. E., Watters, M. R., Poff, P., Grove, J., Selnes, O. A., & Sacktor, N. C. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200501010-00006 · Cited by 97
Dopamine Synthesis and D3 Receptor Activation in Pancreatic β-Cells Regulates Insulin Secretion and Intracellular [Ca2+] Oscillations
Ustione, A., & Piston, D. W. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1226 · Cited by 101
New Twist on Neuronal Insulin Receptor Signaling in Health, Disease, and Therapeutics
Wada, A., Yokoo, H., Yanagita, T., & Kobayashi, H. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05006x · Cited by 95
Insulin Has Multiple Antiamyloidogenic Effects on Human Neuronal Cells
Pandini, G., Pace, V., Copani, A., Squatrito, S., Milardi, D., & Vigneri, R. (2012) · Endocrinology · doi:10.1210/en.2012-1661 · Cited by 103
Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk
Powers, K. M., Smith‐Weller, T., Franklin, G. M., Longstreth, W. T., Swanson, P. D., & Checkoway, H. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.09.004 · Cited by 96
Minireview: Dopaminergic Regulation of Insulin Secretion from the Pancreatic Islet
Ustione, A., Piston, D. W., & Harris, P. E. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1083 · Cited by 98
Metabolic Syndrome, Insulin Resistance, and Cognitive Dysfunction: Does Your Metabolic Profile Affect Your Brain?
Neergaard, J. S., Dragsbæk, K., Christiansen, C., Nielsen, H. B., Brix, S., Karsdal, M. A., & Henriksen, K. (2017) · Diabetes · doi:10.2337/db16-1444 · Cited by 103
Better cognitive performance following a low-glycaemic-index compared with a high-glycaemic-index carbohydrate meal in adults with type 2 diabetes
Papanikolaou, Y., Palmer, H., Binns, M. A., Jenkins, D. J. A., & Greenwood, C. E. (2006) · Diabetologia · doi:10.1007/s00125-006-0183-x · Cited by 94
A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's Disease
Beckett, T. L., Studzinski, C. M., Keller, J. N., Murphy, M. P., & Niedowicz, D. M. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.046 · Cited by 94
Retinal and Cerebral Microvascular Signs and Diabetes
Qiu, C., Cotch, M. F., Sigurdsson, S. O., Garcia, M., Klein, R., Jónasson, F., Klein, B. E. K., Eiríksdóttir, G., Harris, T. B., van Buchem, M. A., et al. (2008) · Diabetes · doi:10.2337/db07-1455 · Cited by 94
EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes
Hyllienmark, L., Maltez, J., Dandenell, A.-K., Ludvigsson, J., & Brismar, T. (2005) · Diabetologia · doi:10.1007/s00125-004-1666-2 · Cited by 93
Cortical Neurons Develop Insulin Resistance and Blunted Akt Signaling: A Potential Mechanism Contributing to Enhanced Ischemic Injury in Diabetes
Kim, B., Sullivan, K. A., Backus, C., & Feldman, E. L. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3816 · Cited by 93
Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation
Gong, Y., Ma, Y., Sinyuk, M., Loganathan, S. N., Thompson, R. C., Sarkaria, J. N., Chen, W., Lathia, J. D., Mobley, B. C., Clark, S. W., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov096 · Cited by 93
Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation
Sattler, F. R., He, J., Letendre, S. L., Wilson, C. C., Sanders, C., Heaton, R. K., Ellis, R. J., Franklin, D., Aldrovandi, G. M., Marra, C. M., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000458 · Cited by 92
Metabolic Syndrome, Brain Magnetic Resonance Imaging, and Cognition
Cavalieri, M., Ropele, S., Petrovic, K., Pluta-Fuerst, A., Homayoon, N., Enzinger, C., Grazer, A., Katschnig, P., Schwingenschuh, P., Berghold, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0851 · Cited by 92
Nutraceuticals against Neurodegeneration: A Mechanistic Insight
Dadhania, V. P., Trivedi, P. P., Vikram, A., & Tripathi, D. N. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160104142223 · Cited by 93
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Austad, S. N., Ballinger, S. W., Buford, T. W., Carter, C. S., Smith, D. L., Darley-Usmar, V. M., & Zhang, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.014 · Cited by 94
Mechanism of action of Daqinjiao decoction in treating cerebral small vessel disease explored using network pharmacology and molecular docking technology
Wang, Z.-Y., Li, M., Li, W., Ouyang, J., Gou, X., & Huang, Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154538 · Cited by 92
Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status
Rodriguez-Rivera, J., Denner, L. A., & Dineley, K. T. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.002 · Cited by 88
Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling
Kang, S., Kim, C. H., Jung, H., Kim, E., Song, H., & Lee, J. E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.029 · Cited by 92
Cardiovascular Disease Risk Factors and Cognitive Impairment
Nash, D. T., & Fillit, H. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.031 · Cited by 88
Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism
Lin, Y., Wang, K., Ma, C., Wang, X., Gong, Z., Zhang, R., Zang, D., & Cheng, Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00227 · Cited by 89
NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
Alrouji, M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., Papadakis, M., Jabir, M. S., Saad, H. M., & Batiha, G. E. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17784 · Cited by 87
Insulin neuroprotection against oxidative stress in cortical neurons--involvement of uric acid and glutathione antioxidant defenses.
Duarte, A. I., Santos, M., Oliveira, C., & Rego, A. (2005) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2005.05.002 · Cited by 79
On the discovery of the genetic association of apolipoprotein E genotypes and common late-onset Alzheimer disease
Roses, A. D. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s340 · Cited by 86
Neuroendocrine abnormalities in Parkinson's disease
Pablo‐Fernández, E. D., Breen, D. P., Bouloux, P. M., Barker, R. A., Foltynie, T., & Warner, T. T. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314601 · Cited by 89

Authors: Craft, S., & Stennis Watson, G.
Affiliations: University of Washington (US)
Corresponding author: Craft, Suzanne
ORCID: Craft, Suzanne
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2004-03
Volume: 3
Issue: 3
Pages: 169-178
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(04)00681-7
OpenAlex: W2145451941
Cited by: 830
References: 145
Citations by year: 2026: 17 · 2025: 26 · 2024: 29 · 2023: 37 · 2022: 36 · 2021: 27 · 2020: 49 · 2019: 42 · 2018: 36 · 2017: 36 · 2016: 43 · 2015: 37 · 2014: 66 · 2013: 44 · 2012: 48
FWCI: 3.57
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (R01-AG-10880, R01AG010880)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK061606, DK61606)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords: insulin, neurodegenerative diseases, brain insulin signaling, Alzheimer's disease, vascular dementia, Parkinson's disease, Huntington's disease, insulin dysregulation, late-life cognitive decline
MeSH terms: Animals, Brain, Cognition Disorders, Diabetes Mellitus, Energy Metabolism, Humans, Insulin, Receptor, Insulin, Signal Transduction, Neurodegenerative Diseases, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Insulin and neurodegenerative disease: shared and specific mechanisms

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks